Parent training intervention leads to significant improvement in sleep problems
Up to 80% of children with autism spectrum disorder (ASD) also have at least moderate sleep disturbances. Disordered sleep in children with autism can amplify already delayed social interactions, repetitive behaviors, affective problems, inattention/hyperactivity and irritability.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
In a prior NIH-funded study (R34MH082882), the principal investigator, Cynthia R. Johnson, PhD, Director of the Cleveland Clinic Children’s Center for Autism, showed that a five-session, individually delivered parent training intervention for young children with ASD and sleep disturbances resulted in significant improvements in sleep problems compared with the control group, which received five sessions of an education program relevant to young children with ASD.1
This study was delivered in a tertiary, specialized setting requiring parents to make many trips to an urban area; some families traveled over two hours to participate. Now, with funding from the Department of Defense, Dr. Johnson and her team will further test this manualized parent training program specifically targeting bedtime and sleep disturbance but delivered via a telehealth platform. This four-year randomized control trial is actively recruiting (email autismresearch@ccf.org for more information). If we demonstrate that this manualized parent training program specifically targeting sleep disturbances can be delivered with fidelity and efficacy via a telehealth platform, this has broad implications for clinical service delivery to reach children and families living at a distance from a specialized autism center.
Advertisement
Advertisement
Tasked-based therapy improves social connection and quality of life
Paired blood and brain tissue methylation findings raise prospect of noninvasive precision diagnosis
Mixed results from phase 2 CALLIPER trial of novel dual-action compound
A co-author of the new recommendations shares the updates you need to know
Success for these complex operations requires judicious patient selection and presurgical patient optimization
Rebound risk is shaped by patient characteristics and mechanism of action of current DMT
First-of-kind prediction model demonstrates high consistency across internal and external validation
Real-world study also finds no significant rise in ocrelizumab-related risk with advanced age